Find a Researcher
David Medina, PhD
Neurobiology
Dr. Medina’s research focuses on developing better methods to target nanoparticles for drug delivery to regions of the central nervous system affected by neurodegenerative or neuromuscular diseases. His eventual goal is to deliver and evaluate new candidate drugs for the treatment of amyotrophic lateral sclerosis.
Generation of two induced pluripotent stem cell (iPSC) lines from an ALS patient with simultaneous mutations in KIF5A and MATR3 genes
Date: 01/2021
Authors: David X. Medina, Ashley Boehringer, Marissa Dominick, Ileana Lorenzini, Sara Saez-Atienzar, Erik P. Pioro, Rita Sattler, Bryan Traynor, Robert Bowser
Risk Factors Underlying COVID-19 Lockdown-Induced Mental Distress
Date: 12/2020
Authors: Jan Sebastian Novotný, Juan Pablo Gonzalez-Rivas, Šárka Kunzová, Mária Skladaná, Anna Pospíšilová, Anna Polcrová, Jose Ramon Medina-Inojosa, Francisco Lopez-Jimenez, Yonas Endale Geda, Gorazd Bernard Stokin
Associations between high triglycerides and arterial stiffness in a population-based sample: Kardiovize Brno 2030 study
Date: 07/2020
Authors: Iuliia Pavlovska, Sarka Kunzova, Juraj Jakubik, Jana Hruskova, Maria Skladana, Irma Magaly Rivas-Serna, Jose R. Medina-Inojosa, Francisco Lopez-Jimenez, Robert Vysoky, Yonas E. Geda, Yonas Endale Geda, Gorazd B. Stokin, Juan P. González-Rivas
Prevalence of ideal cardiovascular health in a Central European community: results from the Kardiovize Brno 2030 Project
Date: 03/2020
Authors: Jose R. Medina-Inojosa, Manlio Vinciguerra, Andrea Maugeri, Sarka Kunzova, Ondřej Sochor, Narine Movsisyan, Yonas E. Geda, Yonas Endale Geda, Gorazd B. Stokin, Francisco Lopez-Jimenez
Intravenously Administered, Retinoid Activating Nanoparticles Increase Lifespan and Reduce Neurodegeneration in the SOD1
Date: 01/2020
Authors: David X. Medina, Eugene P Chung, Collin D Teague, Robert Bowser, Rachael W Sirianni
- English
David Medina, PhD
Neurobiology
Dr. Medina’s research focuses on developing better methods to target nanoparticles for drug delivery to regions of the central nervous system affected by neurodegenerative or neuromuscular diseases. His eventual goal is to deliver and evaluate new candidate drugs for the treatment of amyotrophic lateral sclerosis.
Generation of two induced pluripotent stem cell (iPSC) lines from an ALS patient with simultaneous mutations in KIF5A and MATR3 genes
Date: 01/2021
Authors: David X. Medina, Ashley Boehringer, Marissa Dominick, Ileana Lorenzini, Sara Saez-Atienzar, Erik P. Pioro, Rita Sattler, Bryan Traynor, Robert Bowser
Risk Factors Underlying COVID-19 Lockdown-Induced Mental Distress
Date: 12/2020
Authors: Jan Sebastian Novotný, Juan Pablo Gonzalez-Rivas, Šárka Kunzová, Mária Skladaná, Anna Pospíšilová, Anna Polcrová, Jose Ramon Medina-Inojosa, Francisco Lopez-Jimenez, Yonas Endale Geda, Gorazd Bernard Stokin
Associations between high triglycerides and arterial stiffness in a population-based sample: Kardiovize Brno 2030 study
Date: 07/2020
Authors: Iuliia Pavlovska, Sarka Kunzova, Juraj Jakubik, Jana Hruskova, Maria Skladana, Irma Magaly Rivas-Serna, Jose R. Medina-Inojosa, Francisco Lopez-Jimenez, Robert Vysoky, Yonas E. Geda, Yonas Endale Geda, Gorazd B. Stokin, Juan P. González-Rivas
Prevalence of ideal cardiovascular health in a Central European community: results from the Kardiovize Brno 2030 Project
Date: 03/2020
Authors: Jose R. Medina-Inojosa, Manlio Vinciguerra, Andrea Maugeri, Sarka Kunzova, Ondřej Sochor, Narine Movsisyan, Yonas E. Geda, Yonas Endale Geda, Gorazd B. Stokin, Francisco Lopez-Jimenez
Intravenously Administered, Retinoid Activating Nanoparticles Increase Lifespan and Reduce Neurodegeneration in the SOD1
Date: 01/2020
Authors: David X. Medina, Eugene P Chung, Collin D Teague, Robert Bowser, Rachael W Sirianni
- English